AMPH

COM:AMPHASTAR

Amphastar Pharmaceuticals

  • Stock

31.02

−2.27%

−0.72

USD last updated 15/02 02:24:29

Last Close

31.74

14/02 21:00

Market Cap

1.83B

Beta: -

Volume Today

535.24K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
76.12M
-
76.50M
0.49%
75.21M
1.69%
71.68M
4.69%
66.47M
7.28%
89.91M
35.28%
103.67M
15.30%
94.82M
8.53%
98.20M
3.56%
average payables
15.27M
-
12.02M
21.31%
15.03M
25.11%
16.41M
9.17%
52.02M
216.97%
82.23M
58.07%
86.28M
4.92%
92.52M
7.24%
86.89M
6.09%
average receivables
25.07M
-
28.30M
12.88%
30.14M
6.49%
34.42M
14.20%
47.12M
36.92%
48.95M
3.88%
56.04M
14.48%
72.66M
29.66%
83.95M
15.54%
book value per share
6.72
-
6.57
2.16%
7.26
10.40%
7.32
0.83%
7.17
2.06%
8.12
13.29%
8.55
5.37%
9.33
9.03%
10.89
16.77%
capex per share
-0.49
-
-0.36
26.95%
-0.47
32.03%
-0.76
61.55%
-1.01
32.53%
-0.88
12.33%
-0.72
18.63%
-0.57
20.16%
-0.50
13.86%
capex to depreciation
-1.42
-
-1.21
14.65%
-1.47
21.24%
-2.27
54.88%
-2.83
24.64%
-1.97
30.58%
-1.34
31.66%
-1.03
23.67%
-0.84
18.52%
capex to operating cash flow
-0.97
-
-1.50
54.29%
-0.55
63.09%
-0.90
61.43%
-1.23
36.91%
-1.00
18.81%
-0.59
40.59%
-0.28
52.61%
-0.27
3.81%
capex to revenue
-0.10
-
-0.06
34.50%
-0.08
31.34%
-0.15
74.40%
-0.16
8.70%
-0.13
18.85%
-0.10
24.93%
-0.06
35.19%
-0.05
23.20%
cash per share
1.65
-
1.50
9.33%
1.61
7.21%
1.48
7.87%
1.92
29.88%
1.82
5.47%
2.25
23.59%
2.86
27.40%
3.62
26.55%
days of inventory on hand
188.76
-
148.09
21.55%
192.81
30.20%
155.42
19.39%
134.82
13.26%
211.79
57.10%
171.15
19.19%
142.31
16.85%
151.16
6.21%
days payables outstanding
23.30
-
29.07
24.79%
39.16
34.69%
40.63
3.77%
170.01
318.41%
147.68
13.13%
168.80
14.30%
137.31
18.66%
122.93
10.47%
days sales outstanding
40.11
-
48.57
21.11%
38.33
21.08%
63.88
66.63%
64.67
1.25%
51.73
20.01%
69.27
33.90%
65.81
4.99%
65.08
1.10%
debt to assets
0.11
-
0.11
6.14%
0.09
16.29%
0.10
17.61%
0.10
5.73%
0.11
16.09%
0.11
6.11%
0.16
46.25%
0.14
11.30%
debt to equity
0.16
-
0.14
10.30%
0.11
17.62%
0.14
22.02%
0.15
8.05%
0.17
15.66%
0.17
4.29%
0.23
40.49%
0.19
17.40%
dividend yield
0.11
-
0.03
70.34%
0.01
61.52%
0.02
-
earnings yield
-0.02
-
-0.00
80.17%
0.01
389.27%
0.01
59.67%
-0.01
222.30%
0.05
968.87%
0.00
97.85%
0.06
4,713.59%
0.07
20.34%
0.04
37.54%
enterprise value
462.99M
-
614.82M
32.79%
801.18M
30.31%
868.66M
8.42%
887.14M
2.13%
899.22M
1.36%
920.56M
2.37%
1.09B
18.52%
1.31B
19.78%
enterprise value over ebitda
-27.07
-
150.65
656.58%
51.06
66.11%
-140.54
375.26%
-102.88
26.80%
-23.06K
22,311.48%
84.04
100.36%
15.61
81.42%
12.16
22.13%
ev to operating cash flow
21.99
-
57.56
161.73%
20.78
63.90%
22.15
6.63%
23.23
4.85%
21.53
7.30%
16.08
25.34%
11.13
30.74%
14.65
31.62%
ev to sales
2.20
-
2.44
11.12%
3.14
28.45%
3.62
15.19%
3.01
16.76%
2.79
7.34%
2.63
5.67%
2.49
5.28%
2.62
5.09%
free cash flow per share
0.01
-
-0.12
1,005.51%
0.38
417.21%
0.09
76.45%
-0.19
308.36%
0.00
102.37%
0.50
11,196.20%
1.48
196.64%
1.34
9.12%
2.60
93.40%
free cash flow yield
0.00
-
-0.01
838.79%
0.02
345.05%
0.00
77.46%
-0.01
301.45%
0.00
102.45%
0.02
10,735.59%
0.06
156.14%
0.05
24.46%
0.04
12.38%
graham net net
0.48
-
0.74
52.31%
0.76
2.69%
0.31
59.28%
0.30
3.68%
0.33
10.56%
0.45
37.94%
0.34
24.86%
1.67
389.74%
graham number
6.21
-
3.03
51.23%
6.16
103.32%
4.01
34.83%
4.47
11.30%
13.79
208.89%
2.12
84.64%
16.52
679.62%
21.47
30.02%
income quality
-1.97
-
-3.83
94.77%
3.66
195.53%
8.70
137.56%
-5.73
165.93%
0.90
115.66%
52.20
5,713.11%
1.55
97.03%
0.98
36.96%
1
2.47%
intangibles to total assets
0.11
-
0.10
6.44%
0.12
15.00%
0.10
15.59%
0.08
17.10%
0.07
14.81%
0.06
8.23%
0.06
10.04%
0.05
13.16%
0
100%
interest coverage
-29.53
-
-6.99
76.33%
15.32
319.27%
-1.08
107.07%
-35.49
3,174.98%
-0.33
99.08%
-38.04
11,506.29%
48.74
228.14%
42.66
12.47%
interest debt per share
1.06
-
0.94
11.36%
0.85
8.78%
1.04
21.87%
1.09
4.50%
1.42
30.63%
1.44
1.23%
2.21
53.62%
2.15
2.64%
inventory turnover
1.93
-
2.46
27.46%
1.89
23.20%
2.35
24.06%
2.71
15.29%
1.72
36.35%
2.13
23.75%
2.56
20.26%
2.41
5.85%
invested capital
0.16
-
0.14
10.30%
0.11
17.62%
0.14
22.02%
0.15
8.05%
0.17
15.66%
0.17
4.29%
0.23
40.49%
0.19
17.40%
market cap
487.12M
-
639.80M
31.34%
835.81M
30.64%
887.10M
6.14%
923.26M
4.08%
906.28M
1.84%
945.93M
4.38%
1.11B
17.63%
1.36B
22.26%
3.28B
140.97%
net current asset value
90.49M
-
81.31M
10.14%
85.61M
5.29%
70.44M
17.72%
71.14M
0.99%
95.80M
34.67%
97.17M
1.43%
92.11M
5.20%
164.99M
79.12%
net debt to ebitda
1.41
-
-6.12
533.85%
-2.21
63.94%
2.98
235.16%
4.19
40.44%
181.03
4,221.18%
-2.32
101.28%
-0.31
86.60%
-0.50
60.41%
net income per share
-0.25
-
-0.06
75.69%
0.23
474.45%
0.10
57.88%
-0.12
226.49%
1.04
942.24%
0.02
97.76%
1.30
5,474.77%
1.88
44.78%
2.60
37.87%
operating cash flow per share
0.50
-
0.24
52.65%
0.85
257.72%
0.85
0.07%
0.82
3.20%
0.89
7.98%
1.22
36.96%
2.05
68.47%
1.84
10.44%
2.60
41.28%
payables turnover
15.67
-
12.56
19.87%
9.32
25.76%
8.98
3.63%
2.15
76.10%
2.47
15.12%
2.16
12.51%
2.66
22.94%
2.97
11.70%
receivables turnover
9.10
-
7.51
17.43%
9.52
26.71%
5.71
39.99%
5.64
1.23%
7.06
25.02%
5.27
25.32%
5.55
5.25%
5.61
1.12%
research and ddevelopement to revenue
0.14
-
0.15
9.10%
0.16
9.57%
0.18
11.96%
0.20
8.07%
0.21
9.34%
0.19
10.03%
0.14
27.57%
0.15
7.66%
0.12
17.05%
return on tangible assets
-0.03
-
-0.01
74.21%
0.03
450.67%
0.01
60.55%
-0.01
210.60%
0.09
836.45%
0.00
97.93%
0.10
5,186.11%
0.13
32.08%
revenue per share
5.02
-
5.59
11.52%
5.62
0.52%
5.21
7.37%
6.35
21.93%
6.86
8.03%
7.44
8.40%
9.16
23.20%
10.28
12.17%
11.19
8.91%
roe
-0.04
-
-0.01
75.15%
0.03
439.17%
0.01
58.22%
-0.02
229.16%
0.13
843.46%
0.00
97.88%
0.14
5,013.10%
0.17
23.99%
roic
-0.03
-
-0.01
83.08%
0.03
646.79%
-0.01
121.46%
-0.02
133.86%
-0.00
99.57%
-0.01
10,553.75%
0.06
920.98%
0.10
69.47%
sales general and administrative to revenue
0.17
-
0.17
0.23%
0.16
0.65%
0.19
12.91%
0.17
8.54%
0.16
7.87%
0.14
7.68%
0.12
18.41%
0.09
23.14%
0.09
3.79%
shareholders equity per share
6.72
-
6.57
2.16%
7.26
10.40%
7.32
0.83%
7.17
2.06%
8.12
13.29%
8.55
5.37%
9.33
9.03%
10.89
16.77%
stock based compensation to revenue
0.04
-
0.05
15.55%
0.06
16.33%
0.07
20.03%
0.06
20.43%
0.05
5.22%
0.06
9.21%
0.04
27.14%
0.04
16.15%
tangible asset value
239.29M
-
255.61M
6.82%
278.95M
9.13%
292.19M
4.75%
322.09M
10.23%
386.38M
19.96%
408.11M
5.62%
406.65M
0.36%
491.36M
20.83%
tangible book value per share
5.70
-
5.69
0.32%
6.15
8.14%
6.34
3.08%
6.94
9.55%
8.22
18.46%
8.68
5.50%
8.51
1.90%
10.12
18.90%
working capital
135.40M
-
115.98M
14.34%
123.48M
6.47%
120.59M
2.34%
113.51M
5.87%
165.23M
45.57%
167.48M
1.36%
214.31M
27.96%
283.46M
32.27%

All numbers in USD (except ratios and percentages)